首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >COMPARISON OF EFFICACY OF FERROUS CALCIUM CITRATE vs FERROUS ASCORBATE ON Hb STATUS IN ANAEMIC PREGNANT WOMEN
【24h】

COMPARISON OF EFFICACY OF FERROUS CALCIUM CITRATE vs FERROUS ASCORBATE ON Hb STATUS IN ANAEMIC PREGNANT WOMEN

机译:枸CA酸亚铁钙和抗坏血酸铁对贫血孕妇血红蛋白状态的疗效比较

获取原文
获取外文期刊封面目录资料

摘要

Objectives: To compare the efficacy of ferrous calcium citrate with ferrous ascorbate on Hb levels in anaemic pregnant women. Method: In this observational study, patients receiving ferrous ascorbate with elemental iron 100 mg were allocated to group A and those receiving ferrous calcium citrate with elemental iron 50 mg allocated to group B. After recording the baseline data, their Hb levels, side effects at the end of each month were recorded. Results and discussion: Change in mean Hb levels from baseline to three months is 1.59 ± 0.74, 1.94 ±0.52 in group A and group B respectively with the p value ≤0.05. Group B did show statistically significant difference in terms of change in Hb among primi and multiparous women, contrast to group A. Conclusion: Study reveals that ferrous calcium citrate results in better increase in Hb levels and lesser proportion of side effects in contrast to ferrous ascorbate.
机译:目的:比较柠檬酸亚铁钙和抗坏血酸亚铁对贫血孕妇血红蛋白水平的疗效。方法:在这项观察性研究中,将接受抗坏血酸亚铁和100 mg元素铁的患者分配到A组,将接受柠檬酸亚铁和50 mg元素铁的患者分配到B组。记录基线数据,Hb水平,记录每个月底。结果与讨论:A组和B组从基线到三个月的平均Hb水平变化为1.59±0.74、1.94±0.52,p值≤0.05。与A组相比,B组确实在初产妇和多胎妇女的Hb变化方面显示出统计学上的显着差异。结论:研究表明,与抗坏血酸亚铁相比,柠檬酸亚铁钙导致Hb含量增加更好,副作用比例更小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号